Skip to main content
KyungdongPharm logo

KyungdongPharm — Investor Relations & Filings

Ticker · 011040 ISIN · KR7011040003 KO Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2025-07-02 Director's Dealing
Country KR South Korea
Listing KO 011040

About KyungdongPharm

https://kdpharma.co.kr

KyungdongPharm is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicines. Since its establishment in 1975, the company has focused on producing a broad portfolio of specialized therapeutic drugs and general pharmaceuticals. Its product lines encompass prescription medicines, with a focus on areas such as liver therapy, and over-the-counter products, including its prominent painkiller brand, 'Geunal-N'. The company also manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates. Utilizing advanced production facilities and proprietary technology, KyungdongPharm is dedicated to developing high-quality medicines supported by clinical research to contribute to public health.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Commission and Korea Exchange. It details share acquisitions by a director (Ryu Deok-hee) of Kyungdong Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a Director's Dealing (DIRS) report, as it documents insider transactions by company leadership.
2025-07-02 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for KyungDong Pharmaceutical Co., Ltd. covering the period from 2025.01.01 to 2025.03.31. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the acquisition of shares by a director (Ryu Deok-hee) of Kyungdong Pharmaceutical. This type of filing, which reports personal share transactions by company insiders, is classified as 'Director's Dealing' (DIRS).
2025-05-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the share ownership, changes in holdings, and special relationships of major shareholders (specifically Ryu Gi-seong and related parties) in Kyungdong Pharmaceutical Co., Ltd. This type of filing is used to notify the market of significant changes in share ownership (crossing thresholds or changes in control). In the provided classification schema, 'Major Shareholding Notification' (MRQ) is the correct category for such filings.
2025-04-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This document details the acquisition of shares by a company director (류덕희, Honorary Chairman of Kyungdong Pharm). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2025-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Shareholders' Meeting (AGM). It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, director/auditor appointments, and board compensation limits. This fits the definition of a 'Declaration of Voting Results' (DVA) as it reports the official results from shareholder votes at the annual meeting.
2025-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.